Share
17,617 Posts.
lightbulb Created with Sketch. 2550
clock Created with Sketch. 25/12/21
01:04
Share
Originally posted by whytee
↑
I think you are expecting too much from a single arm study on terminal "unresectable" pancreatic cancer patients. To make some sort of comparison you would have to go to the literature and look at trials of newer chemotherapy cocktails to see how many similar patients were downgraded from unresectable to resectable. My guess is a very small percentage because most of them will result in only an incremental increase in survival time Shrinking unresectable pancreatic cancer sufficiently to convert to potentially resectable with chemothrapy alone would likely gain quite a lot of attention in the literature.
Expand
Perhaps of interest as a starting point for trials on Pancreatic cancer trialshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517959/ https://pubmed.ncbi.nlm.nih.gov/30505595/
Last edited by
whytee :
25/12/21
(20min delay)